丁二烯阴离子聚合动力学及活性种的研究

本文对于n-BuLi/2G引发的丁二烯阴离子聚合动力学数据及产物微观结构进行了解析。建立了动力学模型,提出了聚合反应机理。求得了单量体、一络合体和二络合体的增长速度常数和诸活性种之间的平衡常数以及它们对形成乙烯基结构的贡献。     

WxC-MCM-48催化剂的合成、表征及加氢脱硫催化性能

以正硅酸乙酯(TEOS)为硅源，十六烷基三甲基溴化铵(CTAB)为表面活性剂，仲钨酸铵为钨源，采用水热晶化法一步合成了不同钨含量(以Si、W物质的量比n_Si/n_W表示)的WO₃-MCM-48，然后经甲烷/氢气(V/V=1/4)混和气体程序升温还原碳化(TPC)，制备出了W_xC-MCM-48(x=1、2)催化剂，采用XRD、N₂吸附-脱附和NH₃-TPD对样品的结构进行了表征，用噻吩作为模型化合物，对W_xC-MCM-48催化剂的加氢脱硫催化活性进行了评价。结果表明，在一定钨含量的条件下，WO₃-MCM-48和W_xC-MCM-48样品仍然保持MCM-48的三维立方有序介孔结构，n_Si/n_W=30～15时，碳化钨的物相为W₂C；n_Si/n_W=7.5时，碳化钨为W₂C和WC物相，W_xC-MCM-48催化剂表现出了良好的加氢脱硫催化性能。     

单核铁(Ⅲ)双卟啉配合物在溶液中的构象平衡及其对环己烷羟化反应的催化活性的影响

合成及表征了一系列以柔韧碳氢链相连不同长度的ｐ／ｐ型单核铁（Ⅲ）双卟啉配合物，以可见光谱首次观察到该系列配合物在氯仿溶液中开放式及闭合式构象的平衡，发现６８０ｎｍ处吸收峰强度与这种构象平衡有关，烷氧链越长，该吸收峰强度越大．利用该类配合物模拟了细胞色素Ｐ４５０单加氧酶对环己烷的羟化作用，催化结果表明，在以分子氧为氧源及还原剂存在的温和条件下，该类配合物的催化活性显著高于单核铁卟啉（ＦｅＴＰＰＣｌ），随着柔韧碳氢链长度的增加，双卟啉的催化活性依次增加．高的催化活性与双卟啉配合物在溶液中的构象平衡，即闭合式构象引起的立体位阻及电子转移有关．     

金属络合物的相转移催化分析与分离

以可简单分离回收、可反复使用为目标，详细介绍了相转移催化的变化发展过 程．通过对溶剂的选择，使得催化剂选择性地溶解在某一液相中，而使产物溶解在 另一液相中，如水-有机两相催化体系；通过温度的变化，简单地实现了在较高温 度下反应为均相体系以提高催化剂的活性，而在较低温度下实现了催化剂与产物不 相溶使得催化剂得以简单分离，如温控型水-有机两相催化体系、氟-有机两相催化 体系、温控型含氟催化剂、温控型有机金属催化剂等．     

Gas chromatographic determination of aldicarb and its metabolites in urine

A method is described for the determination of aldicarb and its metabolites (the sulphoxide and sulphone) in urine by gas chromatography with flame photometric detection (GC-FPD). The sample was concentrated with a column containing activated charcoal and Florisil, and then eluted with dichloromethane-acetone (1:1, v/v). The aldicarb and aldicarb sulphoxide in the eluate solution were oxidized to aldicarb sulphone and the total sulphone concentration was determined by GC-FPD after extraction with dichloromethane and clean-up with an activated charcoal column. The detection limit was 0.0024 mg/l. The mean recoveries from spiked urine in the range 0.04-0.12 mg/l were 90.9%, 86.6%, 92.6% for aldicarb, aldicarb sulphoxide and aldicarb sulphone, respectively.     

肝素化聚甲基硅氧烷-聚氧乙烯接枝物的合成及其体外抗凝血性能评价

以二甲基硅油接枝端羟基聚氧乙烯（ＰＤＭＳ ｇ ＰＥＯ ＯＨ）为基材，用二环己基碳二亚胺（ＤＣＣＩ）作脱剂，研究了羟基（ＯＨ）与肝素上的羧基（—ＣＯＯＨ）之间的脱水缩合反应，制备出肝素化的抗血栓材料ＰＤＭＳ ｇ ＰＥＯ Ｈｅｐ，并对其涂覆表面的肝素含量和体外抗凝血性能进行了初步评价．实验结果表明，肝素接枝的共聚物具有优良的抗凝血性能和一定的应用前景．     

Enantioselective iodolactonization catalyzed by chiral quaternary ammonium salts derived from cinchonidine

Chiral quaternary ammonium salts derived from cinchonidine have been applied to catalyze the stereoselective iodolactonizations of trans-5-aryl-4-pentenoic acids leading to a mixture of two regioselectively iodolactonized products with fair to excellent yield (37-98%) and moderate enantioselectivity (exo = 42.0% ee, endo = 31.0% ee) under mild conditions. This work is the first example of asymmetric iodolactonization reaction in the presence of less than a stoichiometric amount of chiral reagent.     

层状MAgTeS3 (M＝K, Rb)的溶剂热合成与表征

以硫醇为螯合剂, 在溶剂热条件下合成了两种层状硫代亚碲酸盐KAgTeS₃ (1)和RbAgTeS₃ (2). X射线单晶解析表明, 1和2是类质同晶化合物. 在晶体结构中, 银硫四面体通过共用顶点形成无限的平行链, 在相邻链中银硫四面体取向相反, 这些链与链由三角锥配位的碲互相连接形成阴离子层状结构, 阳离子在阴离子层间. 1的结晶学数据为: M_r＝370.75, P2₁/c, a＝0.73639(6) nm, b＝1.06468(8) nm, c＝0.85203(6) nm, β＝106.4640(10)°, V＝0.64062(8) nm³, Z＝4, R(F)＝4.44%, wR(F²)＝11.66%. 2的结晶学数据: M_r＝417.12, P2₁/c, a＝0.75531(12) nm, b＝1.07076(7) nm, c＝0.8583(2) nm, β＝106.497(6)°, V＝0.66558(19) nm³, Z＝4, R(F)＝6.00%, wR(F²)＝15.43%. DSC及紫外-可见漫反射光谱研究表明, 这两种化合物为半导体, 并具有很好的热稳定性.     

聚羟基丁酯酯缓释微球的制备及性能

用溶剂蒸发法制备了以新型生物可降解材料聚羟基丁酸酯为载体、以安定为模药的缓释微球,讨论了药物与载体之比对药物含量与包封率的影响,以及制备微球条件对药物释放性能的影响;微球平均粒径为３０～４０μｍ,粒径分布在１～１．５之间,最大载药量为１９．５１％;最高包封率为６７．１１％;体外累积释放曲线呈“两相”释放特征并拌随初始的“突释效应”。扫描电镜观察微球表面呈皱缩表观形态结构,微球内部横断面具有孔道与孔     

Synthesis of N-（α-Alkoxyalkyl）benzotriazoles Catalyzed by Acidic Ionic Liquid at Room Temperature

N-（α-Alkoxyalkyl）benzotriazoles were synthesized via the condensation of benzotriazole with various aldehydes and alcohols catalyzed by acidic ionic liquid [hmim]HSO4 at room temperature. The yield was up to 99%. This novel method was effective when triethoxymethane was utilized instead of alcohols. Moreover, acidic ionic liquid could be reused easily with no significant degradation of its catalytic activity.